30-year old man gets first dose Of India's Covid Vaccine As Human Trial Begins at AIIMS(Delhi)
A total of 12 volunteers were called for a number of pre-tests that include blood and nasopharyngeal testing for COVID-19.
After results, 10 healthy individuals were selected for the vaccine to be given in phases.
After the first dose, a report on their health condition will be submitted to the ethics committee, which will reviewing the entire process.
100 healthy people will be vaccinated at AIIMS during these trial.
Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the ICMR and the National Institute of Virology (NIV), had recently got the approval for human clinical trials from the Drugs Controller General of India (DCGI).
AIIMS-Delhi is among the 12 institutes selected by the Indian Council for Medical Research (ICMR) for conducting the first two phases of the randomised, double-blind, placebo-controlled clinical trials of Covaxin.
By IGNITED MINDS
Comments
Post a Comment